Sensei biotherapeutics to participate in cantor fitzgerald's future of oncology virtual symposium

Boston, march 30, 2023 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer patients, today announced that john celebi, president and chief executive officer, will participate in a panel titled ‘novel approaches in immunotherapy' at cantor fitzgerald's future of oncology virtual symposium on monday, april 3rd at 10.00 a.m. et.
SNSE Ratings Summary
SNSE Quant Ranking